Natera Retained Earnings (Accumulated Deficit) 2014-2024 | NTRA

Natera retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Natera retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-2.514B, a 9.34% increase year-over-year.
  • Natera retained earnings (accumulated deficit) for 2023 were $-2.377B, a 22.38% increase from 2022.
  • Natera retained earnings (accumulated deficit) for 2022 were $-1.943B, a 39.27% increase from 2021.
  • Natera retained earnings (accumulated deficit) for 2021 were $-1.395B, a 50.09% increase from 2020.
Natera Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-2,377
2022 $-1,943
2021 $-1,395
2020 $-929
2019 $-699
2018 $-575
2017 $-446
2016 $-346
2015 $-250
2014 $-180
2013 $-175
Natera Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $-2,514
2024-06-30 $-2,482
2024-03-31 $-2,445
2023-12-31 $-2,377
2023-09-30 $-2,299
2023-06-30 $-2,190
2023-03-31 $-2,080
2022-12-31 $-1,943
2022-09-30 $-1,800
2022-06-30 $-1,679
2022-03-31 $-1,533
2021-12-31 $-1,395
2021-09-30 $-1,254
2021-06-30 $-1,103
2021-03-31 $-987
2020-12-31 $-929
2020-09-30 $-853
2020-06-30 $-795
2020-03-31 $-735
2019-12-31 $-699
2019-09-30 $-664
2019-06-30 $-641
2019-03-31 $-608
2018-12-31 $-575
2018-09-30 $-543
2018-06-30 $-513
2018-03-31 $-479
2017-12-31 $-446
2017-09-30 $-437
2017-06-30 $-410
2017-03-31 $-382
2016-12-31 $-346
2016-09-30 $-308
2016-06-30 $-282
2016-03-31 $-259
2015-12-31 $-250
2015-09-30 $-227
2015-06-30 $-209
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2013-12-31 $-175
Sector Industry Market Cap Revenue
Medical Medical Services $22.082B $1.083B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.361B 11.58
Cencora (COR) United States $48.280B 17.81
DiDi Global (DIDIY) China $22.212B 0.00
ICON (ICLR) Ireland $17.675B 15.74
Viatris (VTRS) United States $15.958B 4.92
Avantor (AVTR) United States $14.143B 21.20
Revvity (RVTY) United States $13.634B 23.68
CochLear (CHEOY) Australia $12.777B 0.00
Solventum (SOLV) United States $12.233B 0.00
BioMerieux (BMXMF) France $11.895B 0.00
Medpace Holdings (MEDP) United States $10.498B 29.58
Charles River Laboratories (CRL) United States $10.011B 19.34
HealthEquity (HQY) United States $9.104B 49.41
Doximity (DOCS) United States $8.999B 52.97
Sonic Healthcare (SKHHY) Australia $8.862B 0.00
Bausch + Lomb (BLCO) Canada $6.892B 32.08
Life Times (LTH) United States $5.081B 33.63
Organon (OGN) United States $3.935B 3.97
Sotera Health (SHC) United States $3.631B 19.42
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.925B 33.35
Concentras Parent (CON) United States $2.789B 0.00
PACS (PACS) United States $2.515B 0.00
Alignment Healthcare (ALHC) United States $2.310B 0.00
Ardent Health Partners (ARDT) United States $2.259B 0.00
Premier (PINC) United States $2.195B 11.42
GeneDx Holdings (WGS) United States $2.162B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GoodRx Holdings (GDRX) United States $1.868B 49.00
Teladoc Health (TDOC) United States $1.828B 0.00
Progyny (PGNY) United States $1.315B 26.62
Pediatrix Medical (MD) United States $1.285B 12.57
CareDx (CDNA) United States $1.241B 0.00
Establishment Labs Holdings (ESTA) $1.206B 0.00
AMN Healthcare Services Inc (AMN) United States $0.984B 6.66
Embecta (EMBC) United States $0.797B 5.32
QDM (QDMI) Hong Kong, SAR China $0.790B 0.00
Agilon Health (AGL) United States $0.779B 0.00
SBC Medicals (SBC) United States $0.674B 0.00
InnovAge Holding (INNV) United States $0.662B 0.00
Auna S.A (AUNA) Luxembourg $0.522B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
DocGo (DCGO) United States $0.434B 16.35
Enhabit (EHAB) United States $0.380B 32.87
COMPASS Pathways (CMPS) United Kingdom $0.302B 0.00
ModivCare (MODV) United States $0.254B 13.79
LifeMD (LFMD) United States $0.251B 0.00
Sera Prognostics (SERA) United States $0.221B 0.00
Biodesix (BDSX) United States $0.186B 0.00
Nutex Health (NUTX) United States $0.179B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
MultiPlan (MPLN) United States $0.112B 0.00
So-Young (SY) China $0.086B 16.60
Ascend Wellness Holdings (AAWH) United States $0.085B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.046B 0.00
NeueHealth (NEUE) United States $0.041B 1.10
IceCure Medical (ICCM) Israel $0.032B 0.00
Co-Diagnostics (CODX) United States $0.032B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.021B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00